Buonamici et al demonstrated Evi1 transduced BM in C57BL6 recipients developed lethal myelodysplastic syndrome (MDS) 8–12 months after bone marrow transplantation (BMT), but none developed AML [10]. This evidence concerns the gene MECOM and acute myeloid leukemia.